Skip to content

EVOLUSENS

Absorbed by VIVEA on 01-01-2025 KBO/BCE: BE 1007.792.683

Last board

2 directors, no change since 2025
Voorzitter, secretaris en controleur
in office according to the deed of 03-10-2025
Director
in office according to the deed of 06-06-2025
listed in the 2024 annual accounts, filed on 29-08-2025
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 03-04-2024

Office holders in the KBO →

Mandates through the years

2 names, the dashed line is today

Director

Voorzitter, secretaris en controleur
LeadershipBoardmandate already running before its first mention
Mandates as a list
    • Director, since before 31-12-2024
    • Voorzitter, secretaris en controleur, since before 03-10-2025
    • Voorzitter, secretaris en controleur, since before 03-10-2025

Control

EVOLUSENS was absorbed by on 01-01-2025.

Capital

Contribution
€1,200
Shares
100
Contribution per share
€12
Equity per share
-€68.83 in 2024
Source
2024 annual accounts

Articles of association

deed of 03-04-2024 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 1 director
“Algemene vergadering bepaalt aantal,duur van opdracht en,indien meerdere,bevoegdheid”
Share issue ruleThe articles set how and by whom new shares are issued.
“Ten minste vijftien dagen te rekenen van dag openstelling intekening, inbreng in geld met uitgifte van nieuwe aandelen”
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Fourth Monday of June

Shareholders

Owners 0

EVOLUSENS was absorbed by on 01-01-2025.
Former owners (1)

Capital transactions

Shareholders according to the deeds
Stated in the deed deed of 03-10-2025 ↗
  • all shares
At incorporation deed of 03-04-2024 ↗
  • sole founder · 100% at incorporation
Capital over time
  1. 03-04-2024 Incorporation · €12,000 · 100 shares

Next steps